Delivery Order SPE2DB20D1100-SPE2DB25FE0YM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a ceiling value of $1,038.82. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and has an ultimate completion date of September 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, valued at $67,741.38, was competitively awarded on July 18, 2025, with an ultimate completion date of July 21, 2025. This delivery order employs firm fixed pricing and carries no set-aside designation. AmerisourceBergen will perform the work at its corporate headquarters in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units) with a contract ceiling value of $1,206.33. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a non-set-aside competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $1,926.55 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tacrolimus 1 mg capsules (100-count units). This firm fixed price contract, which is not set-aside, represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Tacrolimus 1 mg capsules (immediate release) in quantities of 100, with a contract ceiling value of $3,248.74. This is a firm fixed price delivery order with no set-aside designation, awarded competitively under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The ultimate...
- The Defense Logistics Agency awarded a delivery order valued at $1,260.80 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (100 count) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single shipment of this immunosuppressant medication, which is...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $3,512.26 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 1mg in quantities of 100 units. The contract, awarded on August 7, 2025, with an ultimate completion date of September 4, 2025, utilizes firm fixed-price pricing under a non-set-aside competitive procurement. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a $1,169.28 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,566,256,795 Tacrolimus 1 mg capsules to support military treatment facilities and federal healthcare programs. This contract is a task order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a broad range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 100 units of 5 mg Tacrolimus capsules. The $1,903.26 contract has a period of performance through March 22, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor and is the sole awardee of a $999,999,999.00 indefinite delivery contract from DLA to deliver pharmaceuticals...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,767.09, is for the delivery of TACROLIMUS 1 MG CAPSULE (IR) 100S, a medication used for various medical treatments. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0YMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,694.99 to AmerisourceBergen Drug Corp for the supply of Tacrolimus 5 mg capsules (immediate release) in quantities of 100 units. The contract, awarded on September 24, 2025, carries a firm fixed price structure with an ultimate completion date of September 25, 2025, and is not designated as a set-aside contract. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. As a prime vendor for the DLA's global pharmaceutical supply chain, AmerisourceBergen provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and the Defense Health Agency. The IDC vehicle enables the contractor to fulfill federal medical procurement requirements for specialty medications, generic drugs, vaccines, and related medical commodities across multiple therapeutic domains on a competitive, as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/24/25 |